Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Daniela A, Ferraro"'
Autor:
Daniela A. Ferraro, Andreas M. Hötker, Anton S. Becker, Iliana Mebert, Riccardo Laudicella, Anka Baltensperger, Niels J. Rupp, Jan H. Rueschoff, Julian Müller, Ashkan Mortezavi, Marcelo T. Sapienza, Daniel Eberli, Olivio F. Donati, Irene A. Burger
Publikováno v:
European Journal of Hybrid Imaging, Vol 6, Iss 1, Pp 1-15 (2022)
Abstract Background Magnetic resonance imaging (MRI) is recommended by the European Urology Association guidelines as the standard modality for imaging-guided biopsy. Recently positron emission tomography with prostate-specific membrane antigen (PSMA
Externí odkaz:
https://doaj.org/article/dcbc85ce5c564f4690ca9b48418c5633
Autor:
Riccardo Laudicella, Stephan Skawran, Daniela A. Ferraro, Urs J. Mühlematter, Alexander Maurer, Hannes Grünig, Hendrik J. Rüschoff, Niels Rupp, Olivio Donati, Daniel Eberli, Irene A. Burger
Publikováno v:
Insights into Imaging, Vol 13, Iss 1, Pp 1-10 (2022)
Abstract Objectives PSMA PET/MRI showed the potential to increase the sensitivity for extraprostatic disease (EPD) assessment over mpMRI; however, the interreader variability for EPD is still high. Therefore, we aimed to assess whether quantitative P
Externí odkaz:
https://doaj.org/article/a96d6e5229dc4ebda5f2176d4d44a60a
Autor:
Ken Kudura, Tobias Oblasser, Daniela A. Ferraro, Caecilia E. Mader, Lars Husmann, Kerstin Friedrich, Edwin E. G. W. ter Voert, Irene A. Burger
Publikováno v:
European Journal of Hybrid Imaging, Vol 4, Iss 1, Pp 1-10 (2020)
Abstract Background PET/MRI has a high potential in oncology imaging, especially for tumor indications where high soft tissue contrast is crucial such as genitourinary tumors. One of the challenges for PET/MRI acquisition is handling of metal implant
Externí odkaz:
https://doaj.org/article/2a330eb967134ccb86beb9b089210499
Autor:
Daniela A. Ferraro, Francesca Patella, Sara Zanivan, Cinzia Donato, Nicola Aceto, Monica Giannotta, Elisabetta Dejana, Maren Diepenbruck, Gerhard Christofori, Martin Buess
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-13 (2019)
Abstract Background The tumour microenvironment is a critical regulator of malignant cancer progression. While endothelial cells have been widely studied in the context of tumour angiogenesis, their role as modulators of cancer cell invasion and migr
Externí odkaz:
https://doaj.org/article/d0db17bd31394cb094787352d975e11f
Autor:
Stephan Skawran, Michael Messerli, Fotis Kotasidis, Josephine Trinckauf, Corina Weyermann, Ken Kudura, Daniela A. Ferraro, Janique Pitteloud, Valerie Treyer, Alexander Maurer, Martin W. Huellner, Irene A. Burger
Publikováno v:
Life, Vol 12, Iss 9, p 1350 (2022)
Background: Investigation of the clinical feasibility of dynamic whole-body (WB) [18F]FDG PET, including standardized uptake value (SUV), rate of irreversible uptake (Ki), and apparent distribution volume (Vd) in physiologic tissues, and comparison b
Externí odkaz:
https://doaj.org/article/0571c5d2dd2845dc9a1d359927deaf35
Autor:
Ruben I. Hack, Anton S. Becker, Beata Bode-Lesniewska, G. Ulrich Exner, Daniel A. Müller, Daniela A. Ferraro, Geoffrey I. Warnock, Irene A. Burger, Christian Britschgi
Publikováno v:
Life, Vol 11, Iss 9, p 869 (2021)
Introduction: The role of positron-emission tomography/computed-tomography (PET/CT) in the management of sarcomas and as a prognostic tool has been studied. However, it remains unclear which metric is the most useful. We aimed to investigate if volum
Externí odkaz:
https://doaj.org/article/f650eb57f86e4a6ca3bd27f2da834daf
Autor:
Alexander Maurer, Daniela A. Ferraro, Riccardo Laudicella, Niels J. Rupp, Konstantinos Zeimpekis, Olivio F. Donati, Iliana Mebert, Irene A. Burger, Marcelo Tatit Sapienza, Julian Müller, Daniel Eberli, Hannes Grünig, Jan H. Rueschoff
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 49:1721-1730
Purpose Prostate-specific membrane antigen (PSMA)-targeted PET is increasingly used for staging prostate cancer (PCa) with high accuracy to detect significant PCa (sigPCa). [68 Ga]PSMA-11 PET/MRI-guided biopsy showed promising results but also persis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1cc07bbc020cf881fa6f45a8640c71f5
https://doi.org/10.1007/s00259-021-05599-3
https://doi.org/10.1007/s00259-021-05599-3
Autor:
Niels J. Rupp, Irene A. Burger, Riccardo Laudicella, Daniela A. Ferraro, Jan H. Rüschoff, Holger Moch, Thomas Hermanns, Urs J. Muehlematter, Ann-Katrin Rodewald, Daniel Eberli
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 48:4042-4053
Purpose Prostate-specific membrane antigen (PSMA-) PET has become a promising tool in staging and restaging of prostate carcinoma (PCa). However, specific primary tumour features might impact accuracy of PSMA-PET for PCa detection. We investigated hi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6de0e04998715e23bb002be91cd989ad
https://doi.org/10.1007/s00259-021-05501-1
https://doi.org/10.1007/s00259-021-05501-1
Autor:
Irene A. Burger, Christian D. Fankhauser, Philipp A. Kaufmann, Saskia Fassbind, Daniel Eberli, Daniela A. Ferraro, Benedikt Kranzbühler, Matthias Guckenberger, Jean-Jacques Stelmes
Publikováno v:
Annals of Nuclear Medicine
Purpose Prostate-specific membrane antigen (PSMA) targeted positron emission tomography (PET) imaging significantly improved the detection of recurrent prostate cancer (PCa). However, the value of PSMA PET imaging in patients with advanced hormone-se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd7dea338ac53ab738cc26b6abb6624b
http://europepmc.org/articles/PMC8408087
http://europepmc.org/articles/PMC8408087
Autor:
Michael Messerli, Anka Baltensperger, Hannes Grünig, Marcelo Tatit Sapienza, Daniel Eberli, Iliana Mebert, Ashkan Mortezavi, Jan H. Rueschoff, Daniela A. Ferraro, Niels J. Rupp, Olivio F. Donati, Anton S. Becker, Benedikt Kranzbühler, Konstantinos Zeimpekis, Irene A. Burger
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging
Purpose Ultrasound-guided biopsy (US biopsy) with 10–12 cores has a suboptimal sensitivity for clinically significant prostate cancer (sigPCa). If US biopsy is negative, magnetic resonance imaging (MRI)–guided biopsy is recommended, despite a low
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95a82f6ce3b3831ce3cc360ffa1af70e
https://doi.org/10.1007/s00259-021-05261-y
https://doi.org/10.1007/s00259-021-05261-y